At the same time, the final phase continues for a trial of Vertex’s zimislecel (formerly VX-880), a cell-based therapy that does require immunosuppression to protect the immune system from rejecting ...

Let's dive into some prime choices out of from the screener. Overview: Synopsys, Inc. is a company specializing in electronic design automation software for integrated circuits, with a market ...

Let's dive into some prime choices out of from the screener. Overview: Synopsys, Inc. is a company specializing in electronic design automation software for integrated circuits, with a market ...